Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02236429

Vaginal Flora for Treatment of Bacterial Vaginosis

Vaginal Flora Transplantation for Recurrent Bacterial Vaginosis

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Bacterial vaginosis (BV) is the most common vaginal infection in women. It is caused by a vaginal bacterial imbalance. Treatment with antibiotics is the standard of care but there is a high rate of recurrence. Almost half of women successfully treated suffer a recurrence within three months. Complications include risk factors for premature birth, increased transmission of sexually transmitted diseases and higher risk for carcinoma of cervix. The investigators proposed study is a cost effective treatment based on returning the normal microbial balance to the vagina. The investigators propose to transfer normal vaginal flora from healthy individuals to women with BV and thus restore normal vaginal flora and cure this disorder.

Conditions

Interventions

TypeNameDescription
BIOLOGICALvaginal flora transplant

Timeline

Start date
2015-06-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2014-09-10
Last updated
2025-09-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02236429. Inclusion in this directory is not an endorsement.